Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria
- 1 August 2003
- journal article
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 13 (8) , 495-500
- https://doi.org/10.1097/00008571-200308000-00007
Abstract
The primary genetic form of trimethylaminuria (TMAU) is caused by inherited defects in the flavin-containing monooxygenase 3 (FMO3) gene. Defective FMO3 has a decreased ability to catalyze the N-oxygenation of the dietary-derived malodourous amine, trimethylamine. We report two novel deleterious mutations identified in two unrelated individuals affected by the disorder. Sequence analysis of the FMO3 coding exons amplified from genomic DNA revealed that the mutation from individual 1 was heterozygous for a G>A missense mutation in exon 2 of the FMO3 gene. The mutation changed a GAG encoding Glu at codon 32 to AAG encoding Lys. Wild-type and mutant E32K FMO3 were expressed in Escherichia coli as maltose binding-fusion proteins and assayed for their ability to catalyze oxygenation of various FMO3 substrates. The results showed that the E32K mutation abrogated the catalytic activity of the enzyme. Individual 2 was identified as heterozygous for the P153L mutation. In addition, individual 2 was also heterozygous for a novel single nucleotide deletion of A191 in exon 3 at codon 64. The deletion resulted in a frame shift and caused premature termination of the FMO3 gene immediately after codon 65. Family pedigree analysis revealed that the P153L and the deletion mutation were carried on different alleles for this individual. Therefore, both alleles of the FMO3 gene for individual 2 were affected by mutations abolishing the catalytic activity of the enzyme, explaining the severe TMAU condition. The two deleterious mutations reported herein were rare mutations with estimated allelic frequencies of less than 1%.Keywords
This publication has 14 references indexed in Scilit:
- TWO NEW POLYMORPHISMS OF THE FMO3 GENE IN CAUCASIAN AND AFRICAN-AMERICAN POPULATIONS: COMPARATIVE GENETIC AND FUNCTIONAL STUDIESDrug Metabolism and Disposition, 2003
- Interindividual Differences of Human Flavin-Containing Monooxygenase 3: Genetic Polymorphisms and Functional VariationDrug Metabolism and Disposition, 2002
- Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FMO3) gene in patients with fish-odour syndromePharmacogenetics, 2000
- A novel mutation in the flavin-containing monooxygenase 3 gene, FMO3, that causes fish-odour syndrome: activity of the mutant enzyme assessed by proton NMR spectroscopyPharmacogenetics, 2000
- Trimethylaminuria Is Caused by Mutations of the FMO3 Gene in a North American CohortMolecular Genetics and Metabolism, 1999
- Two novel mutations of theFMO3 gene in a proband with trimethylaminuriaHuman Mutation, 1999
- Transient trimethylaminuria in childhoodActa Paediatrica, 1998
- Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxicationHuman Molecular Genetics, 1998
- Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndromeNature Genetics, 1997
- The fish odour syndrome: biochemical, familial, and clinical aspects.BMJ, 1993